Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Mental Health: New approach 'has positive impact'

  • Extracurricular sports produce disciplined preteens

  • 70 percent of college students stressed about finances

  • Novel DNA repair mechanism brings new horizons

  • REM sleep critical for young brain development; medication interferes

  • How the stress hormone cortisol reinforces traumatic memories

  • Documenting how dementia sufferers benefit from GPS

  • Prion trials and tribulations: Finding the right tools and experimental models

  • Puccini?s ?exotic inspiration?:Unusual source of Madam Butterfly's melodies revealed

  • Online reader comments can provide valuable feedback to news sites

  •